VRPX [NASD]
Virpax Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.96 Insider Own1.60% Shs Outstand11.77M Perf Week-2.21%
Market Cap15.48M Forward P/E- EPS next Y- Insider Trans18.46% Shs Float8.72M Perf Month-31.44%
Income-12.10M PEG- EPS next Q- Inst Own18.90% Short Float0.96% Perf Quarter-41.67%
Sales- P/S- EPS this Y-105.70% Inst Trans0.14% Short Ratio0.46 Perf Half Y-68.48%
Book/sh3.18 P/B0.42 EPS next Y- ROA-44.90% Target Price- Perf Year-66.67%
Cash/sh3.16 P/C0.42 EPS next 5Y- ROE-50.20% 52W Range1.25 - 36.00 Perf YTD-61.22%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-96.11% Beta-
Dividend %- Quick Ratio19.00 Sales past 5Y- Gross Margin- 52W Low12.00% ATR0.18
Employees7 Current Ratio19.00 Sales Q/Q- Oper. Margin- RSI (14)34.03 Volatility11.60% 10.91%
OptionableNo Debt/Eq0.00 EPS Q/Q60.10% Profit Margin- Rel Volume1.07 Prev Close1.33
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume181.21K Price1.40
Recom- SMA20-14.76% SMA50-27.63% SMA200-68.64% Volume140,533 Change5.26%
May-19-22 09:00AM  
May-16-22 09:00AM  
May-06-22 06:12AM  
May-05-22 09:00AM  
Apr-26-22 09:00AM  
Mar-31-22 09:00AM  
Mar-22-22 09:00AM  
04:00AM  
Mar-15-22 01:45PM  
10:06AM  
09:00AM  
Feb-15-22 09:00AM  
Feb-10-22 09:00AM  
Jan-21-22 11:00AM  
Jan-18-22 09:00AM  
Jan-04-22 09:20AM  
Dec-28-21 08:00AM  
Dec-20-21 08:00AM  
Dec-08-21 08:00AM  
Dec-01-21 07:16AM  
Nov-27-21 08:04AM  
Nov-15-21 08:00AM  
Nov-10-21 08:00AM  
Oct-20-21 07:00AM  
Oct-06-21 09:00AM  
Oct-01-21 08:00AM  
Sep-20-21 09:00AM  
Sep-16-21 01:00PM  
Sep-14-21 02:49PM  
12:27PM  
10:11AM  
09:05AM  
Sep-13-21 07:07AM  
Sep-02-21 09:00AM  
Aug-26-21 02:51PM  
09:00AM  
Aug-19-21 07:07AM  
05:11AM  
Aug-18-21 02:30PM  
12:09PM  
12:00PM  
10:45AM  
10:33AM  
08:50AM  
07:07AM  
Aug-17-21 02:47PM  
02:31PM  
09:00AM  
Aug-10-21 09:00AM  
Jul-30-21 09:00AM  
Jul-07-21 09:00AM  
Jun-21-21 08:00AM  
Jun-02-21 08:00AM  
May-18-21 08:00AM  
Apr-22-21 08:00AM  
Apr-19-21 12:14PM  
09:00AM  
Apr-05-21 12:54PM  
09:00AM  
Mar-22-21 09:00AM  
Mar-10-21 09:00AM  
Mar-02-21 08:00AM  
Mar-01-21 11:15AM  
Feb-23-21 08:00AM  
Feb-22-21 01:52PM  
Feb-19-21 04:07PM  
Virpax Pharmaceuticals, Inc., a preclinical stage biopharmaceutical company, develops and manufactures non-opioid and non-addictive pharmaceutical products using drug delivery systems for pain management. The company offers products, such as Epoladerm, a diclofenac metered-dose spray film for acute musculoskeletal pain; Probudur (LBL100), long-acting bupivacaine liposomal gel for postoperative pain management; OSF200 for chronic osteoarthritis of the knee; and NES100 (Envelta), an exogenous enkephalin intranasal spray for acute and chronic pain. It also develops PES200 for the management of post-traumatic stress disorder; and MMS019 high-density molecular masking spray to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2 (Covid-19). Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sendrow JerroldDirectorNov 22Buy3.923,90015,3084,506Nov 24 04:30 PM
Mack Anthony P.Chief Executive OfficerNov 18Buy3.9925,125100,249176,812Nov 22 06:00 PM